IBEX Home Investment Highlights Valuation & Metrics Price Chart Why The Stock Moved Return vs. Risk About IBEX Interactive Breakdown Better Bets vs. IBEX Peer Outperformance Latest Trefis Analyses Trade Ideas More From Trefis Peer Comparisons FDIC Bank Data FDA Approved Drugs Data Clinical Pipeline Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Forward Guidance Insider Activity Investor Activity (13F) Trade Sentinel Investor Videos Industry Resource Links External Quote Links

    IBEX (IBEX)

    Market Price (10/9/2026): $44.37 | Market Cap: $-Sector: Information Technology | Industry: IT Consulting & Other Services

    IBEX (IBEX)

    Market Price (10/9/2026): $44.37
    Market Cap: $-
    Sector: Information Technology
    Industry: IT Consulting & Other Services

    Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

    0

    Low stock price volatility
    Vol 12M is 37%

    Trading close to highs
    Dist 52W High is -3.1%, Dist 3Y High is -3.1%

    Key risks
    IBEX key risks include [1] significant client concentration and [2] margin pressure from rising labor costs coupled with rigid lease commitments.

    0 Low stock price volatility
    Vol 12M is 37%
    1 Trading close to highs
    Dist 52W High is -3.1%, Dist 3Y High is -3.1%
    2 Key risks
    IBEX key risks include [1] significant client concentration and [2] margin pressure from rising labor costs coupled with rigid lease commitments.

    IBEX in ETFs

    Weight = IBEX's share of each fund

    VTI0.00%
    IWM0.02%
    AVUV0.08%
    IWO0.02%
    DFAS0.01%
    VTWO0.01%
    DFAC0.00%
    IWN0.00%

    Valuation & Metrics

    null
    null
    null

    AI Analysis | Feedback

    MetricValueDateSource
    Employee Net Promoter Score7711072025Link
    Client Net Promoter Score7111072025Link
    Client Revenue Retentionover 98%11072025Link
    Number of Employeesover 30,00011072025Link
    Number of Operations Facilities3111072025Link
    Revenue Growth from Retail & E-commerce Vertical25.0%11062025Link
    Revenue Growth from HealthTech Vertical19.5%11062025Link
    Revenue Growth from Travel, Transportation and Logistics Vertical15.4%11062025Link
    Client Concentration (Top Client)10% of total revenue11062025Link
    Client Concentration (Top 3 Clients)26% of total revenue11062025Link

    Price Chart

    Recent
    9/10/2026Earnings ReleaseRev: $164 Mil (A) vs. $160 Mil (E)
    EPS: 0.85 (A) vs. $0.84 (E)
    Upcoming
    11/05/2026Earnings ReleaseRev: $169 Mil (E)
    EPS: $0.90 (E)

    Why The Stock Moved

    Qualitative Assessment

    AI Analysis | Feedback

    Updated on 10/1/2026

    IBEX (IBEX) stock has gained about 40% since 6/30/2026 because of the following key factors:

    1. IBEX reported record-breaking financial results for fiscal year 2026, which ended on June 30, 2026, significantly boosting investor confidence. The company achieved record revenue of $644.1 million, marking a 15.4% increase year-over-year. Diluted EPS surged by 32.8% to $3.13, and adjusted EPS rose by 28.3% to $3.52. Furthermore, adjusted EBITDA increased by 14.5% to $82.4 million. This strong performance, which also included record operating cash flow of $59.0 million and free cash flow of $31.2 million, underscored the company's robust operational execution and sustained growth, having delivered six consecutive quarters of double-digit revenue growth.

    2. The company surpassed analyst expectations for its fiscal Q4 2026, demonstrating stronger-than-anticipated performance. For the quarter ended June 30, 2026, IBEX reported revenue of $164.3 million, exceeding analyst consensus estimates of $160.02 million. Adjusted earnings per share of $0.85 also beat the estimated $0.84. This outperformance was notably driven by significant growth in key verticals, with HealthTech revenue increasing by 42.3% and Technology revenue by 27.4% year-over-year.

    Show more
    Updated on 10/1/2026

    IBEX (IBEX) stock has gained about 40% since 6/30/2026 because of the following key factors:

    1. IBEX reported record-breaking financial results for fiscal year 2026, which ended on June 30, 2026, significantly boosting investor confidence. The company achieved record revenue of $644.1 million, marking a 15.4% increase year-over-year. Diluted EPS surged by 32.8% to $3.13, and adjusted EPS rose by 28.3% to $3.52. Furthermore, adjusted EBITDA increased by 14.5% to $82.4 million. This strong performance, which also included record operating cash flow of $59.0 million and free cash flow of $31.2 million, underscored the company's robust operational execution and sustained growth, having delivered six consecutive quarters of double-digit revenue growth.

    2. The company surpassed analyst expectations for its fiscal Q4 2026, demonstrating stronger-than-anticipated performance. For the quarter ended June 30, 2026, IBEX reported revenue of $164.3 million, exceeding analyst consensus estimates of $160.02 million. Adjusted earnings per share of $0.85 also beat the estimated $0.84. This outperformance was notably driven by significant growth in key verticals, with HealthTech revenue increasing by 42.3% and Technology revenue by 27.4% year-over-year.

    3. IBEX's strategic focus and successful expansion into AI-powered and digital customer experience solutions provided a significant growth catalyst. The company has made a strategic shift towards digital and omni-channel delivery, which experienced a 24.7% growth and now accounts for 82% of total revenue. This focus is evidenced by the successful implementation of Generative AI solutions, including two strategic AI Agent wins in fiscal Q4 2026. Recognition for these efforts includes the 2026 Product of the Year Award from CUSTOMER Magazine for its Wave iX AI Virtual Agent and a Silver Globee® Award for AI-powered customer experience excellence.

    4. The introduction of positive fiscal year 2027 guidance, coupled with ongoing share repurchase programs, signaled continued financial health and a commitment to shareholder value. IBEX projected fiscal year 2027 revenue to be between $700 million and $715 million, implying a healthy growth rate of 9% to 11%. Additionally, the company forecasted adjusted EBITDA to be in the range of $90 million to $94 million. These forward-looking projections, alongside the repurchase of approximately 0.5 million shares for $14.4 million during fiscal year 2026 and an authorized $20 million share repurchase program, underscored management's confidence in future performance and its dedication to enhancing shareholder returns.

    Show less
    Holding a concentrated position? Know your true downside before the momentum shifts.
    Protect Your Wealth →

    Stock Movement Drivers

    Fundamental Drivers

    null
    null

    Market Drivers

    6/30/2026 to 10/7/2026
    ReturnCorrelation
    IBEX42.1% 
    Market (SPY)4.1%10.0%
    Sector (XLK)5.7%-24.7%

    Fundamental Drivers

    null
    null

    Market Drivers

    3/31/2026 to 10/7/2026
    ReturnCorrelation
    IBEX60.9% 
    Market (SPY)19.8%5.5%
    Sector (XLK)51.7%-8.4%

    Fundamental Drivers

    null
    null

    Market Drivers

    9/30/2025 to 10/7/2026
    ReturnCorrelation
    IBEX6.5% 
    Market (SPY)17.6%22.5%
    Sector (XLK)43.5%9.7%

    Fundamental Drivers

    null
    null

    Market Drivers

    9/30/2023 to 10/7/2026
    ReturnCorrelation
    IBEX179.4% 
    Market (SPY)88.1%23.6%
    Sector (XLK)150.1%16.1%

    Return vs. Risk

    Price Returns Compared

     202120222023202420252026Total [1]
    Returns
    IBEX Return-31%93%-24%13%78%13%131%
    Peers Return37%-28%-27%-24%-18%-36%-71%
    S&P 500 Return27%-19%24%23%16%14%108%

    Monthly Win Rates [3]
    IBEX Win Rate25%67%58%50%67%50% 
    Peers Win Rate71%42%44%38%46%38% 
    S&P 500 Win Rate75%42%67%75%67%50% 

    Max Drawdowns [4]
    IBEX Max Drawdown-52%-22%-54%-31%-19%-33% 
    Peers Max Drawdown-22%-44%-52%-47%-48%-51% 
    S&P 500 Max Drawdown-5%-25%-10%-8%-19%-9% 

    [1] Cumulative total returns since the beginning of 2021
    [2] Peers: TTEC, CNXC, G, CNDT.
    [3] Win Rate = % of calendar months in which monthly returns were positive
    [4] Max drawdown represents maximum peak-to-trough decline within a year
    [5] 2026 data is for the year up to 10/7/2026 (YTD)

    How Low Can It Go

    EventIBEXS&P 500
    2025 US Tariff Shock
      % Loss-15.9%-18.8%
      % Gain to Breakeven18.9%23.1%
      Time to Breakeven31 days79 days
    Summer-Fall 2023 Five Percent Yield Shock
      % Loss-30.9%-9.5%
      % Gain to Breakeven44.8%10.5%
      Time to Breakeven368 days24 days
    2023 SVB Regional Banking Crisis
      % Loss-28.5%-6.7%
      % Gain to Breakeven39.9%7.1%
      Time to Breakeven646 days31 days

    Compare to TTEC, CNXC, G, CNDT

    In The Past

    IBEX's stock fell -15.9% during the 2025 US Tariff Shock. Such a loss loss requires a 18.9% gain to breakeven.

    Preserve Wealth

    Limiting losses and compounding gains is essential to preserving wealth.

    Asset Allocation

    Actively managed asset allocation strategies protect wealth. Learn more.

    EventIBEXS&P 500
    Summer-Fall 2023 Five Percent Yield Shock
      % Loss-30.9%-9.5%
      % Gain to Breakeven44.8%10.5%
      Time to Breakeven368 days24 days
    2023 SVB Regional Banking Crisis
      % Loss-28.5%-6.7%
      % Gain to Breakeven39.9%7.1%
      Time to Breakeven646 days31 days

    Compare to TTEC, CNXC, G, CNDT

    In The Past

    IBEX's stock fell -15.9% during the 2025 US Tariff Shock. Such a loss loss requires a 18.9% gain to breakeven.

    Preserve Wealth

    Limiting losses and compounding gains is essential to preserving wealth.

    Asset Allocation

    Actively managed asset allocation strategies protect wealth. Learn more.

    About IBEX (IBEX)

    ```html

    IBEX Limited (IBEX) is a global provider of technology-enabled customer lifecycle experience solutions. The company assists businesses with managing their customer interactions and enhancing the overall customer journey from initial acquisition through ongoing support. They achieve this by integrating various communication channels and employing advanced technology to streamline customer engagement and operational efficiency for their clients.

    IBEX offers three primary solutions. "ibex Connect" focuses on customer engagement, providing outsourced services like customer service, technical support, and revenue generation across channels such as voice, email, chat, and social media. "ibex Digital" is geared towards customer acquisition, encompassing digital marketing and e-commerce technology solutions. Lastly, "ibex CX" provides proprietary software tools designed to measure, monitor, and manage clients' customer experience metrics.

    The company serves a diverse range of industries, leveraging its network of customer engagement and acquisition delivery centers. Its clientele spans sectors including banking and financial services, delivery and logistics, health tech and wellness, high tech, retail and e-commerce, streaming and entertainment, and travel and hospitality, demonstrating a broad market reach for its specialized customer experience offerings.

    ```

    AI Analysis | Feedback

    1. Teleperformance for the digital era.

    2. Concentrix combined with a digital marketing agency.

    AI Analysis | Feedback

    • ibex Connect: A customer engagement solution offering outsourced customer service, technical support, revenue generation, and back-office services through various communication channels.
    • ibex Digital: A customer acquisition solution encompassing digital marketing, e-commerce technology, and platform solutions.
    • ibex CX: A customer experience solution providing a suite of proprietary software tools for measuring, monitoring, and managing clients' customer experience.

    AI Analysis | Feedback

    IBEX Limited (symbol: IBEX) sells primarily to other companies, providing technology-enabled customer lifecycle experience solutions.

    The provided company description does not list the names of specific customer companies. However, it indicates that IBEX serves clients across a variety of industries, including:

    • Banking and financial services
    • Delivery and logistics
    • Health tech and wellness
    • High tech
    • Retail and e-commerce
    • Streaming and entertainment
    • Travel and hospitality
    • Utility industries

    AI Analysis | Feedback

    null

    AI Analysis | Feedback

    Robert Dechant, Chief Executive Officer

    Robert Dechant has served as CEO of IBEX since July 2019 and as a director since January 2021. He has been instrumental in leading IBEX's transformation into a technology-led and digitally-driven provider of end-to-end customer lifecycle and digital transformation solutions. Under his leadership, IBEX experienced significant revenue and EBITDA growth, culminating in the company's successful IPO on Nasdaq in August 2020. Prior to his current role, he held positions as CEO of IBEX Global Solutions (2015–2017) and CEO of IBEX Interactive (2017–2019). Dechant also served as Chief Sales/Marketing & Client Services Officer at Qualfon (2012–2015) and Chief Marketing & Operations Officer at Stream Global Services. He holds a B.S. in Mathematics from Fairfield University.

    Taylor Greenwald, Chief Financial Officer

    Taylor Greenwald joined IBEX as Chief Financial Officer in August 2023. In this role, he is responsible for overseeing the company's global financial operations, which include accounting, treasury, business planning and analysis, corporate development, and investor relations. Mr. Greenwald brings over 20 years of experience in leading financial functions for major global public organizations, including Synchronoss Technologies, Endurance International Group, and Convergys Corporation. He earned an MBA from the Massachusetts Institute of Technology Sloan School of Management and a bachelor's degree in engineering from the Georgia Institute of Technology.

    David Afdahl, Chief Operating Officer

    David Afdahl has served as the Chief Operating Officer of IBEX since 2018. His responsibilities include global operations, performance management, and financial results for the company. Mr. Afdahl initially joined IBEX in 2017 as the Vice President of Operations, where he was responsible for U.S. Operations. He possesses more than 23 years of operational leadership experience within the BPO industry. Before joining IBEX, he spent seven years as the Managing Director for Xerox Services, overseeing global operations, client management, and overall financial performance. Mr. Afdahl holds a B.A. degree in Anthropology from the University of Maryland.

    Christy O'Connor, Chief Legal Officer & Assistant Secretary

    Christy O'Connor has served as the General Counsel and Assistant Corporate Secretary for IBEX since March 2018. She has over 25 years of experience as a General Counsel and Chief Legal Officer. Prior to her tenure at IBEX, Ms. O'Connor was the Chief Legal and Compliance Officer at Alorica from 2015 through 2017, and subsequently a legal advisor there. Her previous roles also include serving as the General Counsel and Chief Legal Officer at SourceHOV from 2014 to 2015, and Deputy General Counsel for Stream Global Services from 2011 to 2014. Ms. O'Connor has experience in assisting previous employers with going public and preparing companies for sale. She holds a B.A./M.A. from the University of Chicago and a J.D. from St. Mary's University School of Law.

    Julie Casteel, Chief Marketing and Strategic Accounts Officer

    Julie Casteel has been with IBEX as its Chief Sales & Marketing Officer since 2012. In her role as Chief Marketing and Strategic Accounts Officer, she is responsible for the expansion of both new and existing client relationships.

    AI Analysis | Feedback

    Here are the key risks to IBEX Limited's business:

    1. Client Concentration Risk: IBEX is significantly dependent on a limited number of key clients. For instance, the top five clients collectively represent approximately 37% of the company's revenue, with the largest single client accounting for 10% of revenue. The loss of, or a significant reduction in business from, any of these major clients could materially and adversely impact IBEX's revenue and financial performance.
    2. Intense Competition and Rapid Technological Change, particularly Artificial Intelligence (AI): The customer experience (CX) and Business Process Outsourcing (BPO) industry in which IBEX operates is highly competitive and is undergoing rapid transformation driven by advancements in artificial intelligence and automation. While IBEX is investing in AI initiatives to enhance competitiveness and productivity, there is a risk that these advancements may take longer to translate into direct revenue growth or that competitors could develop superior or more cost-effective solutions. The ability to continuously innovate and adapt to evolving technological standards and client demands is crucial for sustained success.
    3. Geopolitical and Macroeconomic Risks: Given IBEX's extensive international operations, particularly in offshore and nearshore locations such as the Philippines, Jamaica, Pakistan, and Nicaragua, the company is exposed to various geopolitical and macroeconomic risks. These risks include political and social instability, natural disasters, general economic uncertainties like inflation and rising interest rates, and foreign exchange fluctuations. Additionally, wage inflation in key offshore markets could exert pressure on operating margins.

    AI Analysis | Feedback

    null

    AI Analysis | Feedback

    Addressable Markets for IBEX Limited's Main Products and Services

    ibex Connect (Customer Engagement, Technical Support, Revenue Generation, and Back-Office Services)

    • Global Customer Experience (CX) Outsourcing Services Market: The global customer experience outsourcing services market was valued at approximately USD 116.88 billion in 2025 and is projected to grow to USD 350.43 billion by 2034.

    • U.S. Customer Experience Business Process Outsourcing Market: The U.S. customer experience business process outsourcing market generated a revenue of USD 29.21 billion in 2024 and is expected to reach USD 77.62 billion by 2033.

    • Global Business Process Outsourcing (BPO) Market: The global business process outsourcing market was valued at USD 327.01 billion in 2025 and is projected to reach USD 741.60 billion by 2034.

    • U.S. Business Process Outsourcing (BPO) Market: The U.S. business process outsourcing market was valued at USD 96.43 billion in 2025 and is projected to reach USD 204.03 billion by 2033.

    ibex Digital (Digital Marketing, E-commerce Technology, and Platform Solutions)

    • Global Digital Marketing Services Market: The global digital marketing services market is likely to be valued at US$ 750.0 billion in 2026 and is projected to reach US$ 1,300.0 billion by 2033.

    • U.S. SEO & Internet Marketing Market: The U.S. SEO & internet marketing market was valued at USD 103.7 billion in 2024 and is expected to increase to USD 380.2 billion by 2032.

    • Global E-commerce Software Market: The global e-commerce software market size was valued at USD 11.25 billion in 2025 and is projected to grow to USD 44.32 billion by 2034.

    • Global E-commerce Platform Market: The global e-commerce platform market was valued at USD 8.7 billion in 2023 and is estimated to reach USD 27.1 billion by 2032.

    • Global E-commerce Market (Overall): The global e-commerce market size was accounted at USD 21.62 trillion in 2025 and is predicted to increase to USD 83.19 trillion by 2035.

    ibex CX (Customer Experience Software Tools)

    • Global Customer Experience Management (CEM) Software Market: The global customer experience management software market size was valued at USD 14.64 billion in 2024 and is estimated to reach USD 39.70 billion by 2033.

    • Global Customer Experience (CX) Enterprise Software Market: The global Customer Experience (CX) Enterprise Software market is estimated to hit USD 12.5 billion in 2024 and is projected to reach USD 24.7 billion by 2031.

    • U.S. Customer Experience Management Market: The U.S. customer experience management market size was valued at USD 3.80 billion in 2023 and is projected to grow at a CAGR of 13.6% from 2024 to 2030.

    AI Analysis | Feedback

    IBEX Limited (IBEX) is expected to drive future revenue growth over the next 2-3 years through several key strategies:

    • Increased Client Acquisition and Expansion: IBEX aims to expand its revenue by acquiring new clients and increasing its share with existing clients. The company has a "new logo engine" that continues to win "trophy clients" and gain significant market share from competitors.
    • Growth in Digital and Omni-channel Service Offerings: The company is experiencing a favorable shift towards digital and omni-channel delivery, which has shown significant growth and constitutes a large percentage of its total revenue. These higher-margin services are expected to continue strengthening.
    • Deployment and Integration of Generative AI Solutions: IBEX's strategic focus on the full-scale implementation of Generative AI solutions is anticipated to be a key driver of future growth. The company views its AI solutions, partnerships, and deployments as a competitive differentiator, with AI-driven initiatives expected to gain traction and lead to AI-first operations.
    • Targeted Growth in High-Margin Verticals: Expansion within high-margin industry verticals, particularly HealthTech, is a significant growth vector. HealthTech has shown strong year-over-year growth and is projected to reach $100 million by year-end. Other strong performing verticals include Retail & E-commerce and Travel, Transportation & Logistics.
    • Geographic Expansion: The company's expansion into new geographies, specifically India, is identified as a high-growth vector and a crucial driver for future revenue. IBEX has established new sites in India with a growing number of agents.

    AI Analysis | Feedback

    ```html

    Share Repurchases

    • IBEX announced a new $15 million share repurchase plan on May 8, 2025, set to commence on May 12, 2025, and remain valid for 12 months.
    • On November 19, 2024, IBEX repurchased 3,562,341 common shares from The Resource Group International, Limited (TRGI) for a total of $70 million, which led to the company no longer being a "controlled company".
    • During fiscal year 2024, IBEX repurchased 1.3 million shares totaling $21.7 million.

    Share Issuance

    • The number of shares outstanding for IBEX has decreased, with 13.36 million shares outstanding at the end of 2025, down from 15.12 million in 2024 and 17.88 million in 2023, primarily due to share buybacks.

    Capital Expenditures

    • Capital expenditures for the full fiscal year 2024 were $8.9 million.
    • Capital expenditures for the full fiscal year 2023 were $19.0 million.
    • As of May 8, 2025, expected capital expenditures were anticipated to remain in the range of $15 million to $20 million.
    ```

    Peer Outperformance in IT Consulting & Other Services

    IBEX has outperformed 78% of its 27 IT Consulting & Other Services peers over 5Y. IT Consulting & Other Services ranks 10th of 12 industries in Information Technology by median 5Y return. The sector’s gains have largely come from elsewhere.
    Share of IT Consulting & Other Services constituents that IBEX has outperformed, by holding period. Peers without a full price history over a given window are excluded from that window.
    1Y
    82%
    of 34 industry peers · 15.7% return
    3Y
    72%
    of 29 industry peers · 172.6% return
    5Y
    78%
    of 27 industry peers · 152.3% return
    No IT Consulting & Other Services peer with a comparable growth profile has beaten IBEX by more than 20pp over 5Y.
    Median price return by industry across the Information Technology sector, ranked by 5Y. IT Consulting & Other Services is IBEX's own industry. Use this to see which corners of the sector have carried the returns.
    Industry Names 1Y med3Y med5Y med Top 3 by 5Y
    Electronic Manufacturing Services 9 63.7%185.7%385.5% TTMI 870% · FLEX 767% · SANM 455%
    Semiconductor Materials & Equipment 27 91.1%106.8%126.6% AXTI 890% · KLAC 534% · LRCX 530%
    Technology Distributors 9 48.0%87.7%97.7% CLMB 420% · AVT 215% · SNX 175%
    Electronic Components 26 34.0%79.6%75.6% CLS 3883% · BELFA 1307% · COHR 485%
    Communications Equipment 36 4.9%95.6%67.2% AAOI 1705% · LITE 1220% · FEIM 882%
    Semiconductors 55 27.4%55.5%35.5% POET 1721% · MU 1489% · NVDA 1045%
    Technology Hardware, Storage & Peripherals 20 23.6%112.9%33.9% SMCI 1119% · DELL 1104% · STX 1064%
    Internet Services & Infrastructure 6 -9.0%37.6%20.6% DOCN 52% · VRSN 45% · GDDY 39%
    Electronic Equipment & Instruments 26 -18.6%29.6%-7.0% PI 263% · KEYS 136% · VPG 114%
    IT Consulting & Other Services ← 28 -23.3%-10.5%-21.5% CHRN 520163% · TSSI 840% · APLD 826%
    Application Software 125 -25.2%-15.5%-44.0% VIDA 1459900% · INLX 4997% · PLTR 726%
    Systems Software 71 -17.4%26.7%-52.1% QNC 581% · PAYS 471% · SANG 402%
    Median of constituents with a full price history over each window. Top names are unfiltered by size in this render.

    Latest Trefis Analyses

    TitleDate
    0DASHBOARDS 
    1IBEX Earnings Notes12/16/2025
    2Is IBEX Stock Built to Withstand a Pullback?10/17/2025
    Title
    0ARTICLES

    Recent Active Movers

    Top Gainers

    TickerCompanyMkt Cap (B)1W RtnYTD Rtn
    RXORXO4.838.6%124.4%
    PTCPTC22.238.0%11.1%
    OPCHOption Care Health4.737.9%-2.7%
    PENGPenguin Solutions3.732.8%271.2%
    MATMattel4.729.3%-17.5%
    PRMEPrime Medicine0.727.7%12.4%
    CIENCiena63.426.9%90.9%
    CTVACorteva9.724.0%-78.3%
    HTZHertz Global0.724.0%-59.7%
    AAOIApplied Optoelectronics10.023.5%251.5%

    Top Losers

    TickerCompanyMkt Cap (B)1W RtnYTD Rtn
    AVBPArriVent BioPharma0.8-44.2%-16.1%
    ACRSAclaris Therapeutics0.5-35.4%13.0%
    NKTRNektar Therapeutics1.3-33.5%-4.8%
    EMATEvolution Metals & Technologies1.1-31.4%-91.8%
    SECZSecuritize1.7-21.9%-7.3%
    SPHRSphere Entertainment3.8-21.0%11.7%
    IARTIntegra Lifesciences1.0-20.1%4.7%
    TWSTTwist Bioscience9.7-19.5%390.7%
    ODTXOdyssey Therapeutics0.5-18.6%10.1%
    ALMRAlamar Biosciences1.6-18.5%26.2%

    Top Gainers

    TickerCompanyMkt Cap (B)1M RtnYTD Rtn
    MYPSPLAYSTUDIOS0.6804.1%579.4%
    KODKodiak Sciences5.7159.7%225.8%
    PACBPacific Biosciences of California0.8106.1%45.5%
    GRALGRAIL5.768.0%55.3%
    DNAGinkgo Bioworks0.765.3%38.0%
    MXLMaxLinear9.761.4%515.9%
    BALYBallys0.853.6%-16.3%
    PEverpure50.850.9%128.0%
    ACVAACV Auctions1.848.5%30.2%
    IOVAIovance Biotherapeutics5.848.4%373.1%

    Top Losers

    TickerCompanyMkt Cap (B)1M RtnYTD Rtn
    CTVACorteva9.7-83.2%-78.3%
    LQDALiquidia2.4-60.6%-22.6%
    XNDUXanadu Quantum Technologies1.3-53.2%-61.0%
    QUREuniQure1.5-49.3%-3.3%
    NKTRNektar Therapeutics1.3-46.6%-4.8%
    EMATEvolution Metals & Technologies1.1-45.1%-91.8%
    AVBPArriVent BioPharma0.8-44.2%-16.1%
    ACRSAclaris Therapeutics0.5-43.9%13.0%
    PCTPureCycle Technologies0.7-41.6%-55.8%
    XENEXenon Pharmaceuticals3.6-38.9%-18.8%

    More From Trefis

    Research & Analysis

    Invest in Strategies

    Wealth Management

    Peer Comparisons

    Peers to compare with:

    Financials

    IBEXTTECCNXCGCNDTMedian
    NameIBEX TTEC Concentr.Genpact Conduent  
    Mkt Price43.121.5226.2533.641.6026.25
    Mkt Cap-0.11.65.70.20.9
    Rev LTM-2,0419,9695,2502,7914,021
    Op Inc LTM-84499789-34292
    FCF LTM-41575549-73295
    FCF 3Y Avg-1486523-79244
    CFO LTM-86787644-1365
    CFO 3Y Avg-47716610-4329

    Growth & Margins

    IBEXTTECCNXCGCNDTMedian
    NameIBEX TTEC Concentr.Genpact Conduent  
    Rev Chg LTM--4.8%2.6%6.5%-5.7%-1.1%
    Rev Chg 3Y Avg--6.3%16.7%6.0%-9.5%-0.2%
    Rev Chg Q--11.3%-1.2%7.1%-11.9%-6.2%
    QoQ Delta Rev Chg LTM--2.8%-0.3%1.7%-2.5%-1.4%
    Op Inc Chg LTM--4.3%-18.0%7.3%60.0%1.5%
    Op Inc Chg 3Y Avg--18.9%-8.6%10.2%-125.0%-13.7%
    Op Mgn LTM-4.1%5.0%15.0%-1.2%4.6%
    Op Mgn 3Y Avg-4.1%6.0%14.8%-1.1%5.0%
    QoQ Delta Op Mgn LTM--0.1%-0.1%0.0%-0.1%-0.1%
    CFO/Rev LTM-4.2%7.9%12.3%-0.0%6.0%
    CFO/Rev 3Y Avg-2.2%7.4%12.4%-0.2%4.8%
    FCF/Rev LTM-2.0%5.8%10.5%-2.6%3.9%
    FCF/Rev 3Y Avg-0.1%5.0%10.6%-2.6%2.6%

    Valuation

    IBEXTTECCNXCGCNDTMedian
    NameIBEX TTEC Concentr.Genpact Conduent  
    Mkt Cap-0.11.65.70.20.9
    P/S-0.00.21.10.10.1
    P/Op Inc-0.93.27.2-7.32.0
    P/EBIT--0.6-0.86.8-2.5-0.7
    P/E--0.4-0.79.8-1.1-0.5
    P/CFO-0.92.08.8-248.51.4
    Total Yield--292.7%-144.2%12.4%-91.8%-118.0%
    Dividend Yield-0.0%5.8%2.1%0.0%1.1%
    FCF Yield 3Y Avg-9.8%22.3%8.1%-20.1%8.9%
    D/E-12.62.70.23.43.1
    Net D/E-11.32.60.22.52.5

    Returns

    IBEXTTECCNXCGCNDTMedian
    NameIBEX TTEC Concentr.Genpact Conduent  
    1M Rtn10.1%10.1%-18.4%-9.4%-17.5%-9.4%
    3M Rtn31.2%-27.3%24.8%15.3%4.6%15.3%
    6M Rtn54.1%-37.4%-2.4%-7.9%11.9%-2.4%
    12M Rtn15.6%-59.2%-42.4%-15.7%-40.3%-40.3%
    3Y Rtn172.4%-93.9%-64.3%-1.4%-53.2%-53.2%
    1M Excs Rtn15.2%11.7%-8.8%-6.0%-4.7%-4.7%
    3M Excs Rtn27.8%-34.2%23.8%10.7%3.2%10.7%
    6M Excs Rtn39.1%-53.1%-17.5%-22.9%-3.1%-17.5%
    12M Excs Rtn-1.1%-74.8%-57.9%-32.3%-57.1%-57.1%
    3Y Excs Rtn98.0%-179.5%-146.4%-83.2%-136.6%-136.6%

    Comparison Analyses

    null

    Segment Financials

    Revenue by Segment
    $ Mil20252024202320222021
    Single Segment558509523493443
    Total558509523493443


    Price Behavior

    Price Behavior
    Market Price$43.16 
    Market Cap ($ Bil)0.6 
    First Trading Date08/07/2020 
    Distance from 52W High-3.1% 
       50 Days200 Days
    DMA Price$38.89$33.50
    DMA Trendupup
    Distance from DMA11.0%28.8%
     3M1YR
    Volatility34.7%37.2%
    Downside Capture4.5182.30
    Upside Capture142.4184.08
    Correlation (SPY)11.7%22.8%
    IBEX Betas & Captures as of 9/30/2026

     1M2M3M6M1Y3Y
    Beta1.561.060.410.200.660.67
    Up Beta-1.861.24-0.48-0.200.200.36
    Down Beta0.740.26-0.31-0.300.650.97
    Up Capture284%172%171%96%73%65%
    Bmk +ve Days6162766132424
    Stock +ve Days14284073133406
    Down Capture38%-6%-40%-11%92%83%
    Bmk -ve Days16263760120328
    Stock -ve Days8142453116337

    [1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
    Based On 1-Year Data
    Annualized
    Return    		Annualized
    Volatility    		Sharpe
    Ratio    		Correlation
    with IBEX
    IBEX14.8%37.2%0.44-
    Sector ETF (XLK)40.8%26.5%1.269.7%
    Equity (SPY)16.8%13.0%0.9222.8%
    Gold (GLD)3.2%29.5%0.11-5.1%
    Commodities (DBC)44.6%20.9%1.66-13.3%
    Real Estate (VNQ)1.6%13.7%-0.1315.3%
    Bitcoin (BTCUSD)-31.7%44.2%-0.7317.7%

    Smart multi-asset allocation framework can stack odds in your favor. Learn How
    Based On 5-Year Data
    Annualized
    Return    		Annualized
    Volatility    		Sharpe
    Ratio    		Correlation
    with IBEX
    IBEX20.1%47.3%0.54-
    Sector ETF (XLK)22.7%25.9%0.7715.4%
    Equity (SPY)13.8%17.1%0.6220.3%
    Gold (GLD)18.4%18.9%0.793.7%
    Commodities (DBC)10.3%19.6%0.40-3.1%
    Real Estate (VNQ)0.8%18.8%-0.0718.2%
    Bitcoin (BTCUSD)15.5%52.2%0.468.6%

    Smart multi-asset allocation framework can stack odds in your favor. Learn How
    Based On 10-Year Data
    Annualized
    Return    		Annualized
    Volatility    		Sharpe
    Ratio    		Correlation
    with IBEX
    IBEX10.7%52.0%0.51-
    Sector ETF (XLK)25.0%25.0%0.9016.8%
    Equity (SPY)15.5%17.9%0.7321.1%
    Gold (GLD)11.5%16.4%0.574.0%
    Commodities (DBC)8.4%18.1%0.381.4%
    Real Estate (VNQ)4.2%20.7%0.1616.8%
    Bitcoin (BTCUSD)64.0%66.2%1.047.0%

    Smart multi-asset allocation framework can stack odds in your favor. Learn How

    Short Interest

    Short Interest: As Of Date9152026
    Short Interest: Shares Quantity0.4 Mil
    Short Interest: % Change Since 8312026-3.7%
    Average Daily Volume0.2 Mil
    Days-to-Cover Short Interest2.1 days

    Returns Analyses

    Earnings Returns History

    Updated 9/21/2026
    Expand for More
     Forward Returns
    Earnings Date1D Returns5D Returns21D Returns
    9/10/20266.8%9.8% 
    5/6/202616.5%8.3%6.5%
    2/5/20262.3%-12.9%-12.6%
    11/6/2025-0.0%-2.4%-2.4%
    9/11/202536.5%37.9%17.8%
    5/8/202519.1%10.3%14.7%
    2/6/202510.9%23.3%12.0%
    11/7/2024-0.3%0.6%4.1%
    ...
    SUMMARY STATS   
    # Positive998
    # Negative444
    Median Positive10.9%9.8%13.3%
    Median Negative-4.7%-13.6%-10.9%
    Max Positive36.5%37.9%17.8%
    Max Negative-25.3%-19.0%-12.6%
     Collapse to Preview
     Forward Returns
    Earnings Date1D Returns5D Returns21D Returns
    9/10/20266.8%9.8% 
    5/6/202616.5%8.3%6.5%
    2/5/20262.3%-12.9%-12.6%
    11/6/2025-0.0%-2.4%-2.4%
    9/11/202536.5%37.9%17.8%
    5/8/202519.1%10.3%14.7%
    2/6/202510.9%23.3%12.0%
    11/7/2024-0.3%0.6%4.1%
    9/12/202416.9%19.5%15.5%
    5/9/20245.4%9.8%15.1%
    2/8/2024-9.1%-14.3%-11.7%
    11/9/20233.3%5.2%8.8%
    9/13/2023-25.3%-19.0%-10.1%
    SUMMARY STATS   
    # Positive998
    # Negative444
    Median Positive10.9%9.8%13.3%
    Median Negative-4.7%-13.6%-10.9%
    Max Positive36.5%37.9%17.8%
    Max Negative-25.3%-19.0%-12.6%

    SEC Filings

    Expand for More
    Report DateFiling DateFiling
    06/30/202609/10/202610-K
    03/31/202605/06/202610-Q
    12/31/202502/05/202610-Q
    09/30/202511/06/202510-Q
    06/30/202509/11/202510-K
    03/31/202505/08/202510-Q
    12/31/202402/06/202510-Q
    09/30/202411/07/202410-Q
    06/30/202409/12/202410-K
    03/31/202405/09/202410-Q
    12/31/202302/08/202410-Q
    09/30/202311/09/202310-Q
    06/30/202309/13/202310-K
    03/31/202305/17/20236-K
    12/31/202202/15/20236-K
    09/30/202211/15/20226-K
     Collapse to Preview
    Report DateFiling DateFiling
    06/30/202609/10/202610-K
    03/31/202605/06/202610-Q
    12/31/202502/05/202610-Q
    09/30/202511/06/202510-Q
    06/30/202509/11/202510-K
    03/31/202505/08/202510-Q
    12/31/202402/06/202510-Q
    09/30/202411/07/202410-Q
    06/30/202409/12/202410-K
    03/31/202405/09/202410-Q
    12/31/202302/08/202410-Q
    09/30/202311/09/202310-Q
    06/30/202309/13/202310-K
    03/31/202305/17/20236-K
    12/31/202202/15/20236-K
    09/30/202211/15/20226-K
    06/30/202210/04/202220-F
    03/31/202205/18/20226-K
    12/31/202102/16/20226-K
    09/30/202111/22/20216-K
    06/30/202110/14/202120-F
    03/31/202105/18/20216-K
    12/31/202002/18/20216-K
    09/30/202011/16/20206-K
    06/30/202010/23/202020-F
    03/31/202008/10/2020424B4
    12/31/201703/19/2018F-1/A
    09/30/201702/23/2018F-1

    Recent Forward Guidance

    Updated 10/4/2026

    Latest: Q4 2026 Earnings Reported 9/10/2026

    Forward GuidanceGuidance Change
    MetricSourceLowMidHigh% Chg% DeltaChangePrior
    Q1 2027 RevenueReported168.00 Mil169.00 Mil170.00 Mil   
    Q1 2027 Revenue GrowthReported11.0%11.5%12.0%   
    Q1 2027 Adjusted EBITDAReported22.00 Mil22.50 Mil23.00 Mil   
    Q1 2027 Adjusted EBITDA GrowthReported13.0%15.5%18.0%   
    2027 RevenueReported700.00 Mil707.50 Mil715.00 Mil10.5% Higher NewGuidance: 640.00 Mil for 2026
    2027 Revenue GrowthReported9.0%10.0%11.0%   
    2027 Adjusted EBITDAReported90.00 Mil92.00 Mil94.00 Mil10.8% Higher NewGuidance: 83.00 Mil for 2026
    2027 Adjusted EBITDA GrowthReported9.0%11.5%14.0%   
    2027 Capital ExpendituresReported25.00 Mil27.50 Mil30.00 Mil0.0% Same NewGuidance: 27.50 Mil for 2026


    Prior: Q3 2026 Earnings Reported 5/6/2026

    Forward GuidanceGuidance Change
    MetricSourceLowMidHigh% Chg% DeltaChangePrior
    2026 RevenueReported638.00 Mil640.00 Mil642.00 Mil2.4% RaisedGuidance: 625.00 Mil for 2026
    2026 Adjusted EBITDAReported82.00 Mil83.00 Mil84.00 Mil2.5% RaisedGuidance: 81.00 Mil for 2026
    2026 Capital ExpendituresReported25.00 Mil27.50 Mil30.00 Mil10.0% RaisedGuidance: 25.00 Mil for 2026

    Q2 2026 Earnings Reported 2/5/2026

    Forward GuidanceGuidance Change
    MetricSourceLowMidHigh% Chg% DeltaChangePrior
    2026 RevenueReported620.00 Mil625.00 Mil630.00 Mil2.0% RaisedGuidance: 612.50 Mil for 2026
    2026 Adjusted EBITDAReported80.00 Mil81.00 Mil82.00 Mil1.9% RaisedGuidance: 79.50 Mil for 2026
    2026 Capital ExpendituresReported 25.00 Mil 11.1% RaisedGuidance: 22.50 Mil for 2026

    Q1 2026 Earnings Reported 11/6/2025

    Forward GuidanceGuidance Change
    MetricSourceLowMidHigh% Chg% DeltaChangePrior
    2026 RevenueReported605.00 Mil612.50 Mil620.00 Mil2.1% RaisedGuidance: 600.00 Mil for 2026
    2026 Adjusted EBITDAReported78.00 Mil79.50 Mil81.00 Mil3.2% RaisedGuidance: 77.00 Mil for 2026
    2026 Capital ExpendituresReported20.00 Mil22.50 Mil25.00 Mil0 AffirmedGuidance: 22.50 Mil for 2026

    Insider Activity

    Updated 10/2/2026
    Expand for More
    #OwnerTitleHoldingActionFiling DatePriceSharesTransacted
    Value    		Value of
    Held Shares    		Form
    1Dechant, Robert ThomasChief Executive OfficerDirectSell929202645.025,000225,09611,570,404Form
    2Trofimuk-O'Connor, Christina AliceChief Legal OfficerDirectSell916202639.342,37693,4761,056,527Form
    3Inson, Paul JosephChief People OfficerDirectSell916202640.072,500100,1651,090,751Form
    4Casteel, Julie KChief Sales/Marketing OfficerDirectSell916202640.4117,474706,0654,073,551Form
    5Ballou-Aares, Daniella DirectSell916202640.291,50060,436418,825Form
     Collapse to Preview
    #OwnerTitleHoldingActionFiling DatePriceSharesTransacted
    Value    		Value of
    Held Shares    		Form
    1Dechant, Robert ThomasChief Executive OfficerDirectSell929202645.025,000225,09611,570,404Form
    2Trofimuk-O'Connor, Christina AliceChief Legal OfficerDirectSell916202639.342,37693,4761,056,527Form
    3Inson, Paul JosephChief People OfficerDirectSell916202640.072,500100,1651,090,751Form
    4Casteel, Julie KChief Sales/Marketing OfficerDirectSell916202640.4117,474706,0654,073,551Form
    5Ballou-Aares, Daniella DirectSell916202640.291,50060,436418,825Form
    6Trofimuk-O'Connor, Christina AliceChief Legal OfficerDirectSell916202640.307,500302,2521,178,015Form
    7Dechant, Robert ThomasChief Executive OfficerDirectSell916202639.9925,000999,66810,476,955Form
    8Zhuang, Mingzhe DirectSell916202640.105,522221,444112,807Form
    9Afdahl, David MartinChief Operating OfficerDirectSell915202640.0710,819433,4835,176,110Form
    10Inson, Paul JosephChief People OfficerDirectSell915202640.002,27490,9601,188,960Form
    11Afdahl, David MartinChief Operating OfficerDirectSell910202637.0917,500649,0085,192,291Form
    12Casteel, Julie KChief Sales/Marketing OfficerDirectSell616202630.613,600110,1833,599,141Form
    13McGinnis, Patrick DirectSell529202631.691,03032,641184,848Form
    14Greenwald, Taylor CChief Financial OfficerDirectSell527202632.0296430,8671,992,605Form
    15Dechant, Robert ThomasChief Executive OfficerDirectSell513202630.507,800237,8978,710,869Form
    16Dawson, Bruce NeilChief Sales and CS OfficerDirectSell513202631.1215,260474,8241,925,900Form
    17Dawson, Bruce NeilChief Sales and CS OfficerDirectSell513202632.803,129102,6432,530,977Form
    18Ballou-Aares, Daniella DirectSell417202635.0150017,505372,611Form
    19Ballou-Aares, Daniella DirectSell417202624.226,000145,304269,854Form
    20Dechant, Robert ThomasChief Executive OfficerDirectSell223202628.466,000170,7537,837,724Form
    21Dechant, Robert ThomasChief Executive OfficerDirectSell220202629.406,000176,3988,273,252Form
    22Dechant, Robert ThomasChief Executive OfficerDirectSell220202629.736,000178,3588,543,546Form
    23Dechant, Robert ThomasChief Executive OfficerDirectSell218202629.986,000179,8548,795,021Form
    24Dechant, Robert ThomasChief Executive OfficerDirectSell218202629.636,000177,7868,871,699Form
    25Inson, Paul JosephChief People OfficerDirectSell211202634.982,62791,892960,866Form
    26Inson, Paul JosephChief People OfficerDirectSell1002202539.5869727,588194,580Form
    27Trofimuk-O'Connor, Christina AliceChief Legal OfficerDirectSell1002202539.581,00139,621552,323Form
    28Dawson, Bruce NeilChief Sales and CS OfficerDirectSell1002202539.5895937,960267,617Form
    29Casteel, Julie KChief Sales/Marketing OfficerDirectSell1002202539.5880631,9041,120,872Form
    30Afdahl, David MartinChief Operating OfficerDirectSell1002202539.581,10343,6592,260,556Form
    31Greenwald, Taylor CChief Financial OfficerDirectSell1002202539.581,27550,4671,444,027Form
    32Dechant, Robert ThomasChief Executive OfficerDirectSell1002202539.586,711265,6337,908,899Form

    IBEX — Investor Video Playlist

    Industry Resources

    Information Technology Resources
    TechCrunch
    Wired
    CIO
    MIT Technology Review
    Gartner Insights
    Ars Technica
    IT Consulting & Other Services Resources
    IDC
    Forrester
    Consultancy.org

    External Quote Links


    Prefer one of these to Trefis? Tell us why.
    Core Cache Last Updated: 10/7/2026